Recommendation and Comments

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP78-06180A000200110003-1
• Release Decision: RIPPUB
• Original Classification: S
• Document Page Count: 2
• Document Creation Date: November 17, 2016
• Document Release Date: July 28, 2000
• Sequence Number: 3
• Publication Date: January 4, 1971
• Content Type: MF

Approved For Release=gQQ/(8/21 : CIA-RDP78-06180A000200110003-1
4 January 1971
MEMORANDUM FOR: Director of Medical Services
SUBJECT : Recommendation and Comments
MEDSIGN
Medical Assignability & Examinee Control
DESIGN REQUIREMENTS STATEMENT
1. As requested, a review of MEDSIGN proposal has been
accomplished. I have included bot
in this review. It is our recommendation that you non-concur in
the proposed design as it is now written.
2. Our recommendation is based primarily on our belief that
the proposal gathers too much detailed medical information about
the status of an individual and that such data then would become
an integral part of the Human Resources System. It is our belief
that no one outside OMS need know, for example, that an individual
be he on duty or an applicant, has been disqualified for an assign-
ment or for employment on psychiatric grounds. The design of
the system is too broad and should be split. The "medical assign-
ability" we believe rightly belongs in the Human Resources System.
An "examinee control" system should be an internal OMS managed
and controlled system.
For purposes of incorporation into Human Resources System
the design phase could be approved as outlined up through the
end of the f irst paragraph at the top of page 9 of the document.
It is our recommendation that if such a limited system be used
then the SSN should be used as requested by SIPS.
It is our recommendation that any "examinee control system"
similar to that requested in D/MS memorandum of 22 October 1968
(Tab D) be a part of what is referred to in the preface of this
document as MEDSTAT. As stated earlier, it is our belief that
25X1A9a
Approved For Release 2000/08/21 : CIA-RDP78-06180A000200110003-1
 Approved For Re asd 20,00/08/21 : CIA-RDP78-06180A000200110003-1
SUBJECT: Review of MEDSIGN Design Requirements Statement
such a system develops sensitive and confidential medical data
which should be controlled by OMS and not open to manipulation
or use by other components in the Human Resources Systems. With
the response to the preliminary program call recently presented,
it is believed that the DD/S would support OMS position in developing
and controlling its own data.
3. In terms of conversion it is our recommendation that
option number one, page 22 be followed. In terms of Hardware/
Software Requirements as described on page 23, we object to
concurring in a unilateral decision by HRS/SIPS on the input
mode. It is our recommendation that terminals be used at both
and Headquarters.
25X1A6a
4. The inclusion of MEDSIGN of Immunization Branch at this
time is, in our view, premature and requires further OMS study.
25X1A9a
It is recommended that along with the personnel
concerned with immunization procedures and records study this
25X1A9a
topic further. With the departure of
25X1A9a
ition should be aware of this subject.
i
s new pos
in h
asked
h
d
25X1A9a
ave
I
He has expressed an interest to an
to involve him in these activities.
25X1A9a
5. As a final observation, although this document refers to
MEDANE package of PSS, there is no reference to the SAT project
of PS under guidance as being a part of MEDSTAT.
There is no mention of OD activities in the computer field and
such may well be inappropriate. There is, however, I believe, a
need for central cognizance and coordination in OMS of those matters
relating to clinical activities in keeping with OMS concept of
the establishment of an Integrated Health and Evaluation System.
For that reason I believe the Medical Systems Development officer
should formally be designated the officer in OMS responsible for
cognizance and coordination of these activities in CD, PS, S PD
and PSS.
Assistant Director for
Clinical Activities
Attachment
Approved For Release 2009/09/21 : CIA-RDP78-06180A000200110003-1
25X1A9a
25X1A9a